1. Home
  2. LEGN vs NOV Comparison

LEGN vs NOV Comparison

Compare LEGN & NOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • NOV
  • Stock Information
  • Founded
  • LEGN 2014
  • NOV 1862
  • Country
  • LEGN United States
  • NOV United States
  • Employees
  • LEGN N/A
  • NOV N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • NOV Metal Fabrications
  • Sector
  • LEGN Health Care
  • NOV Industrials
  • Exchange
  • LEGN Nasdaq
  • NOV Nasdaq
  • Market Cap
  • LEGN 7.0B
  • NOV 5.6B
  • IPO Year
  • LEGN 2020
  • NOV 1996
  • Fundamental
  • Price
  • LEGN $37.19
  • NOV $14.26
  • Analyst Decision
  • LEGN Strong Buy
  • NOV Buy
  • Analyst Count
  • LEGN 12
  • NOV 16
  • Target Price
  • LEGN $79.50
  • NOV $19.60
  • AVG Volume (30 Days)
  • LEGN 1.2M
  • NOV 4.3M
  • Earning Date
  • LEGN 03-11-2025
  • NOV 04-24-2025
  • Dividend Yield
  • LEGN N/A
  • NOV 2.10%
  • EPS Growth
  • LEGN N/A
  • NOV N/A
  • EPS
  • LEGN N/A
  • NOV 1.60
  • Revenue
  • LEGN $627,241,000.00
  • NOV $8,870,000,000.00
  • Revenue This Year
  • LEGN $121.45
  • NOV $0.35
  • Revenue Next Year
  • LEGN $65.49
  • NOV $3.17
  • P/E Ratio
  • LEGN N/A
  • NOV $8.91
  • Revenue Growth
  • LEGN 119.97
  • NOV 3.34
  • 52 Week Low
  • LEGN $30.17
  • NOV $13.78
  • 52 Week High
  • LEGN $69.24
  • NOV $21.20
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 54.69
  • NOV 40.75
  • Support Level
  • LEGN $33.94
  • NOV $13.78
  • Resistance Level
  • LEGN $35.77
  • NOV $15.41
  • Average True Range (ATR)
  • LEGN 1.82
  • NOV 0.49
  • MACD
  • LEGN -0.11
  • NOV -0.07
  • Stochastic Oscillator
  • LEGN 61.16
  • NOV 26.97

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About NOV NOV Inc.

NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing nearly two thirds of its annual revenue.

Share on Social Networks: